Descripción

Classification and clinical presentation of female-pattern hair loss (FPHL), also known as female androgenetic alopecia. The review updates current understanding of this prevalent condition and its impact on quality of life.

Figure 1

Photograph

Source Paper

Female-pattern hair loss: therapeutic update.

Anais brasileiros de dermatologia (2023)

PMID: 37003900

DOI: 10.1016/j.abd.2022.09.006

Cite This Figure

![Figure 1: Classification and clinical presentation of female-pattern hair loss (FPHL), also known as female androgenetic alopecia. The review updates current understanding of this prevalent condition and its impact on quality of life.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334345/bin/gr1.jpg)

> Source: Paulo Müller Ramos et al. "Female-pattern hair loss: therapeutic update.." *Anais brasileiros de dermatologia*, 2023. PMID: [37003900](https://pubmed.ncbi.nlm.nih.gov/37003900/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334345/bin/gr1.jpg" alt="Classification and clinical presentation of female-pattern hair loss (FPHL), also known as female androgenetic alopecia. The review updates current understanding of this prevalent condition and its impact on quality of life." />
  <figcaption>Figure 1. Classification and clinical presentation of female-pattern hair loss (FPHL), also known as female androgenetic alopecia. The review updates current understanding of this prevalent condition and its impact on quality of life.<br>  Source: Paulo Müller Ramos et al. "Female-pattern hair loss: therapeutic update.." <em>Anais brasileiros de dermatologia</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37003900/">37003900</a></figcaption>
</figure>

Evidencia relacionada

Minoxidil para Alopecia Androgenética

Calificación A · 299 estudios

Minoxidil para Pérdida Capilar de Patrón Femenino

Calificación A · 111 estudios

Finasteride para Alopecia Androgenética

Calificación A · 206 estudios